TITLE

News Committee for the Society for Research on Nicotine and Tobacco Treatment Network: Policy Issues

AUTHOR(S)
Pergadia, Michele L.; Cropsey, Karen L.; Forray, Ariadna; Ikomi, Jolomi T.; Peters, Erica N.; West, Robert
PUB. DATE
May 2014
SOURCE
Nicotine & Tobacco Research;May2014, Vol. 16 Issue 5, p634
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on tobacco treatment policy issues in the United States as of 2014. It states the Family Smoking Prevention and Tobacco Control Act (TCA), passed in 2009, and the Affordable Care Act (ACA), passed in 2010, will have evolving implications for tobacco treatment efforts. It mentions the TCA provides the Food and Drug Administration the authority to regulate tobacco products. It talks about the impact of the ACA on tobacco cessation due to higher insurance premiums for smokers.
ACCESSION #
95480086

 

Related Articles

  • Obama Care backlash. MORRIS, DICK // Hill;3/20/2013, Vol. 20 Issue 33, p31 

    The author discusses the implications of the Patient Protection and Affordable Care Act (PPACA) of ObamaCare act, which will be effective in 2014, on health insurance premiums.

  • Premiums may rise 40 percent under PPACA. MAYER, KATHRYN // Benefits Selling;Jul2013, Vol. 11 Issue 7, p12 

    The article offers information on the result of a study performed by Milliman consulting firm which showed that a 40% increase on health insurance premiums might be seen under the Patient Protection and Affordable Care Act.

  • Reading between the lines of ACA. Carson, Stephanie // Charlotte Post;12/12/2013, Vol. 39 Issue 14, p4A 

    The article reports on the increase of the health insurance premiums as a result of the Patient Protection and Affordable Care Act (ACA) in the U.S.

  • E-cigarette use penalized. Johnson, Steven Ross // Modern Healthcare;9/2/2013, Vol. 43 Issue 35, p4 

    The article offers information on the manufacturers of electronic cigarettes that are facing new restrictions in from large employers. It informs that a growing number of employers, contributions for employees identified as including UPS and Wal-Mart Stores Inc., have considered them as an...

  • Sparking controversy. Johnson, Steven Ross // Modern Healthcare;9/23/2013, Vol. 43 Issue 38, p6 

    The article presents information on the rise in the use of electronic cigarette which has put the safety experts in dilemma over the safety and effectiveness as harm reduction devices. It informs that as per the critics there is not enough research to determine the long-term health effects of...

  • E-cigarette use penalized. Johnson, Steven Ross // Modern Healthcare;9/2/2013, Vol. 43 Issue 35, p4 

    The article offers information on the manufacturers of electronic cigarettes that are facing new restrictions in from large employers. It informs that a growing number of employers, contributions for employees identified as including UPS and Wal-Mart Stores Inc., have considered them as an...

  • THE DEVIL IS IN THE DETAILS: HEALTH-CARE REFORM, BIOSIMILARS, AND IMPLEMENTATION CHALLENGES FOR THE FOOD AND DRUG ADMINISTRATION. Paradise, Jordan // Jurimetrics: The Journal of Law, Science & Technology;Spring2011, Vol. 51 Issue 3, p279 

    The Biologics Price Competition and Innovation Act (BPCIA), part of the Patient Protection and Affordable Care Act (PPACA), placed a major regulatory challenge in front of the Food and Drug Administration (FDA). The BPCIA grants broad authority to the FDA to develop and implement a market...

  • Biosimilar Milestone. BaƱuelos, Heather D.; Reschovsky, Allison // Contract Pharma;Apr2012, Vol. 14 Issue 3, p18 

    The article focuses on the draft guidance represented by the U.S. Food & Drug Administration in order to assist the pharmaceutical industry in developing biosimilar products. It states that the pathway for licensure of biosimilar products was founded by the Biologics Price Competition and...

  • COMMENT: THE FDA'S MENU LABELING REGULATION: PROMOTING CHANGE THROUGH SHOCK VALUE. Vieder, Rachael // Health Law & Policy;Spring2012, Vol. 6 Issue 1, p15 

    The article comments on the role of the U.S. Food and Drug Administration (FDA) in tackling obesity issues faced by the nation. It also discusses relationship between the FDA and industries affected by the implementation of Section 4205 of the Patient Protection and Affordable Care Act (PPACA)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics